Company Financials
Colfax Corporation Financials
United States dollar
business
Colfax Corporation Company Profile
Main Stock Listing
NYSE: CFX
Market Capitalization $2.57 Billion as of Jan. 1, 2025
Market Cap History
Valuations Metrics as of Jan. 25, 2025
| Trailing PE | 28.55 |
| Forward PE | 14.52 |
| Price to Sales TTM | $0.67 |
| Price to Book MRQ | $-25.75 |
| Enterprise to Revenue | 1.07 |
| Enterprise to EBITDA | 7.39 |
Financial Reports as of Mar. 31, 2022
Financials
| Fiscal Year Ends | 2021-12-31 |
| Most Recent Quarter | 2022-03-31 |
| Profit Margin | 41.87% |
| Operating Margin | % |
| Return on Assets TTM | 2.32% |
| Return on Equity TTM | 97.94% |
Income Statement
| Revenue TTM | $3,854,303,000 |
| Revenue per Share TTM | $ |
| Quarterly Revenue Growth | 0.01% |
| Gross Profit TTM | $1,613,658,000 |
| EBITDA | $557,138,000 |
| Net Income to Common TTM | $71,657,000 |
| Diluted EPS TTM | $ |
| Quarterly Earnings Growth YoY | 16.40% |
Balance Sheet
| Total Cash MRQ | $0 |
| Total Cash per Share MRQ | $ |
| Total Debt MRQ | $ |
| Total Debt to Equity MRQ | 50.39 |
| Current Ratio MRQ | 2.19 |
| Book Value per Share MRQ | $0.83 |
Cash Flow
| Operating Cash Flow TTM | $340,010,000 |
| Levered Free Cash Flow TTM | $2,504,858,000 |
CFX Stock Info as of Jan. 25, 2025
Stock Statistics
| Shares Outstanding | 53,776,700 |
| Float Shares | None |
| Avg 10 Volume | 361,034 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | % |
| % Held by Institutions | % |
Stock Price Summary
| Beta | |
| Fifty Two Week Low | $38.27 |
| Fifty Two Week High | $65.03 |
| Fifty Two Week Change | -27.83% |
| Day 50 MA | $0.00 |
| Day 200 MA | $0.00 |
Dividends and Splits
| Forward Annual Dividend Rate | $ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | $ |
| Trailing Annual Dividend Yield | % |
| Payout Ratio | % |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date | 2022-04-05 |